Showing results (2471-2480 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1995
Comparative efficacy of DMP 840 against mouse and human solid tumor modelsP LoRusso, L Demchik, M Dan, et al.Investigational New Drugs|January 1, 1995
Phase II study of topotecan in metastatic hormone-refractory prostate cancerG R Hudes, R Kosierowski, R Greenberg, et al.Investigational New Drugs|January 1, 1995
Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center studyF Rosen, E E Vokes, T Lad, et al.Investigational New Drugs|January 1, 1995
Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming units in vitroH Depenbrock, M Wenger, R Peter, et al.Investigational New Drugs|January 1, 1995
Activity of the morpholino anthracycline 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming units in vitroA A Ebrahim el-Zayat, M A Izquierdo, G M Clark, et al.Investigational New Drugs|January 1, 1995
Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group studyM Slavik, P Y Liu, E H Kraut, et al.Investigational New Drugs|January 1, 1995
Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer. A Southwest Oncology Group studyS K Williamson, M K Wolf, M A Eisenberger, et al.Investigational New Drugs|December 28, 2007
PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivoI K Choi, Y H Kim, J S Kim, et al.Investigational New Drugs|January 9, 2008
Extrinsic nitric oxide donor partially reverses arginine deiminase induced cell growth inhibition through NFkappaB and Bcl-X LJae Hong Seo, Hwa Jung Sung, Chul Won Choi, et al.Investigational New Drugs|January 11, 2017
Sunitinib-paracetamol sex-divergent pharmacokinetics and tissue distribution drug-drug interaction in miceMing Hui Liew, Salby Ng, Chii Chii Chew, et al.Pageof 372